Effect of rIL-21 on Metastases in Lymph Nodes in Melanoma Skin Cancer
Status:
Terminated
Trial end date:
2008-06-25
Target enrollment:
Participant gender:
Summary
The trial is conducted in Europe. This trial aims for a comparison of the pathology in lymph
nodes before and after the effect of recombinant interleukin-21 in patients with stage III
melanoma